CA 2024 * | 120 M 109 M | CA 2025 * | 130 M 118 M | Capitalisation | 96,08 M 86,89 M |
---|---|---|---|---|---|
Résultat net 2024 * | -16 M -14,47 M | Résultat net 2025 * | 1 M 904 k | VE / CA 2024 * | 0,8 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,74 x |
PER 2024 * |
-5,94
x | PER 2025 * |
202
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,77% |
Dernier transcript sur Depomed Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 01/02/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 01/07/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 06/03/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 01/11/03 |
James Tyree
BRD | Director/Board Member | 71 | 01/10/16 |
William McKee
BRD | Director/Board Member | 62 | 01/03/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+33,09% | 709 Md | |
+30,90% | 595 Md | |
-2,18% | 367 Md | |
+20,27% | 334 Md | |
+4,99% | 289 Md | |
+14,32% | 239 Md | |
+9,04% | 211 Md | |
-3,35% | 203 Md | |
+8,58% | 171 Md |